EDESA BIOTECH, INC. Increase (Decrease) in Accounts Receivable
EDESA BIOTECH, INC. (EDSA) reported Increase (Decrease) in Accounts Receivable of -$1.15 million for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2023-08-09
- EDESA BIOTECH, INC. increase (decrease) in accounts receivable for the quarter ending 2023-06-30 was -$11.30K, a 106.74% decline year-over-year.
- EDESA BIOTECH, INC. increase (decrease) in accounts receivable for the quarter ending 2023-03-31 was -$2.20M.
- EDESA BIOTECH, INC. increase (decrease) in accounts receivable for the quarter ending 2022-12-31 was $1.06M, a 145.01% increase year-over-year.
- EDESA BIOTECH, INC. increase (decrease) in accounts receivable for the quarter ending 2022-09-30 was $3.93M.
- EDESA BIOTECH, INC. increase (decrease) in accounts receivable for fiscal 2022 was $2.03M, a 37.23% decline from fiscal 2021.
- EDESA BIOTECH, INC. increase (decrease) in accounts receivable for fiscal 2021 was $3.23M, a 2440.65% increase from fiscal 2020.
- EDESA BIOTECH, INC. increase (decrease) in accounts receivable for fiscal 2020 was $127.13K.
- EDESA BIOTECH, INC. increase (decrease) in accounts receivable for fiscal 2018 was -$4.03K.
| Period end | Increase (Decrease) in Accounts Receivable 1 month | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$11.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | -$2.21M derived: sum of 2 quarters · filed 2023-08-09 | -$1.15M 10-Q · filed 2023-08-09 | $2.78M derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2023-03-31 | -$2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | -$1.14M 10-Q · filed 2023-05-11 | $2.79M derived: sum of 3 quarters · filed 2023-05-11 | $2.96M derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2022-12-31 | $1.06M 10-Q · filed 2023-02-10 | $4.99M derived: sum of 2 quarters · filed 2023-02-10 | $5.16M derived: sum of 3 quarters · filed 2023-08-09 | $2.66M derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2022-09-30 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16 | $4.10M derived: sum of 2 quarters · filed 2023-08-09 | $1.59M derived: sum of 3 quarters · filed 2023-08-09 | $2.03M 10-K · filed 2022-12-16 | |||||
| 2022-06-30 | $167.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | -$2.33M derived: sum of 2 quarters · filed 2023-08-09 | -$1.90M 10-Q · filed 2023-08-09 | -$2.68M derived: sum of 4 quarters · filed 2023-08-09 | |||||
| 2022-03-31 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | -$2.07M 10-Q · filed 2023-05-11 | -$2.85M derived: sum of 3 quarters · filed 2023-05-11 | -$6.40M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $432.79K 10-Q · filed 2023-02-10 | -$345.77K derived: sum of 2 quarters · filed 2023-02-10 | -$3.90M derived: sum of 3 quarters · filed 2023-02-10 | $3.74M derived: sum of 4 quarters · filed 2023-02-10 | |||||
| 2021-09-30 | -$778.56K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16 | -$4.33M derived: sum of 2 quarters · filed 2022-12-16 | $3.31M derived: sum of 3 quarters · filed 2022-12-16 | $3.23M 10-K · filed 2022-12-16 | -$3.23M 10-K · filed 2021-12-28 | ||||
| 2021-06-30 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | $4.08M derived: sum of 2 quarters · filed 2022-08-12 | $4.01M 10-Q · filed 2022-08-12 | -$4.01M 10-Q · filed 2021-08-13 | $3.98M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $7.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $7.56M 10-Q · filed 2022-05-13 | $7.54M derived: sum of 3 quarters · filed 2022-05-13 | $7.82M derived: sum of 4 quarters · filed 2022-05-13 | |||||
| 2020-12-31 | -$75.13K 10-Q · filed 2022-02-14 | $75.13K 10-Q · filed 2021-02-16 | -$104.36K derived: sum of 2 quarters · filed 2022-02-14 | $179.15K derived: sum of 3 quarters · filed 2022-02-14 | $160.89K derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | -$29.23K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | $254.28K derived: sum of 2 quarters · filed 2021-12-28 | $236.01K derived: sum of 3 quarters · filed 2021-12-28 | $127.13K 10-K · filed 2021-12-28 | -$127.13K 10-K · filed 2020-12-07 | ||||
| 2020-06-30 | $283.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $265.24K derived: sum of 2 quarters · filed 2021-08-13 | $156.36K 10-Q · filed 2021-08-13 | -$156.36K 10-Q · filed 2020-08-12 | $29.63K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$18.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | -$127.15K 10-Q · filed 2021-05-14 | -$253.87K derived: sum of 3 quarters · filed 2021-05-14 | -$156.27K derived: sum of 4 quarters · filed 2021-05-14 | |||||
| 2019-12-31 | -$108.88K 10-Q · filed 2021-02-16 | -$235.61K derived: sum of 2 quarters · filed 2021-02-16 | -$138.00K derived: sum of 3 quarters · filed 2021-02-16 | -$118.54K derived: sum of 4 quarters · filed 2021-02-16 | |||||
| 2019-09-30 | -$126.73K derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07 | -$29.12K derived: sum of 2 quarters · filed 2020-12-07 | -$9.74K 10-K · filed 2020-12-07 | -$12.77K derived: sum of 4 quarters · filed 2020-12-07 | |||||
| 2019-06-30 | $97.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-12 | $116.99K 10-Q · filed 2019-08-14 | $113.96K 10-Q · filed 2020-08-12 | $144.89K derived: sum of 4 quarters · filed 2020-08-12 | |||||
| 2019-03-31 | $19.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | $16.36K 10-Q · filed 2020-05-15 | -$1.18K 10-Q · filed 2019-05-08 | $47.28K derived: sum of 3 quarters · filed 2020-05-15 | -$5.19K derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | -$3.11K 10-Q · filed 2020-02-13 | $30.47K 10-Q · filed 2019-02-05 | $27.82K derived: sum of 2 quarters · filed 2020-02-13 | -$24.65K derived: sum of 3 quarters · filed 2020-02-13 | -$4.03K 10-KT · filed 2019-12-12 | ||||
| 2018-09-30 | $30.92K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | -$21.55K derived: sum of 2 quarters · filed 2018-11-30 | $30.29K derived: sum of 3 quarters · filed 2019-05-08 | $40.00K 10-K · filed 2018-11-30 | |||||
| 2018-06-30 | -$52.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$3.98K 10-Q · filed 2019-08-14 | $9.08K 10-Q · filed 2018-08-08 | -$1.59K derived: sum of 4 quarters · filed 2019-05-08 | |||||
| 2018-03-31 | $51.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $61.55K 10-Q · filed 2019-05-08 | $50.88K derived: sum of 3 quarters · filed 2019-05-08 | -$3.13K derived: sum of 4 quarters · filed 2019-05-08 | |||||
| 2017-12-31 | $9.71K 10-Q · filed 2019-02-05 | -$955.00 derived: sum of 2 quarters · filed 2019-02-05 | -$54.96K derived: sum of 3 quarters · filed 2019-02-05 | -$2.19K derived: sum of 4 quarters · filed 2019-02-05 | |||||
| 2017-09-30 | -$10.67K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | -$64.67K derived: sum of 2 quarters · filed 2018-11-30 | -$11.91K derived: sum of 3 quarters · filed 2018-11-30 | -$84.57K 10-K · filed 2018-11-30 | |||||
| 2017-06-30 | -$54.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$1.24K derived: sum of 2 quarters · filed 2018-08-08 | -$73.91K 10-Q · filed 2018-08-08 | $2.88K derived: sum of 4 quarters · filed 2018-08-08 | |||||
| 2017-03-31 | $52.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07 | -$19.90K 10-Q · filed 2018-05-07 | $56.88K derived: sum of 3 quarters · filed 2018-05-07 | $55.48K derived: sum of 4 quarters · filed 2018-05-07 | |||||
| 2016-12-31 | -$72.67K 10-Q · filed 2018-02-07 | $4.12K derived: sum of 2 quarters · filed 2018-02-07 | $2.72K derived: sum of 3 quarters · filed 2018-02-07 | -$22.55K derived: sum of 4 quarters · filed 2018-02-07 | |||||
| 2016-09-30 | $76.78K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $75.38K derived: sum of 2 quarters · filed 2017-12-01 | $50.12K derived: sum of 3 quarters · filed 2017-12-01 | -$71.83K 10-K · filed 2017-12-01 | |||||
| 2016-06-30 | -$1.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | -$26.67K derived: sum of 2 quarters · filed 2017-08-09 | -$148.61K 10-Q · filed 2017-08-09 | -$103.94K derived: sum of 4 quarters · filed 2017-12-01 | |||||
| 2016-03-31 | -$25.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09 | -$147.21K 10-Q · filed 2017-05-09 | -$102.53K derived: sum of 3 quarters · filed 2017-12-01 | -$6.42K derived: sum of 4 quarters · filed 2017-12-01 | |||||
| 2015-12-31 | -$121.94K 10-Q · filed 2017-02-06 | -$77.27K derived: sum of 2 quarters · filed 2017-12-01 | $18.84K derived: sum of 3 quarters · filed 2017-12-01 | $17.00 derived: sum of 4 quarters · filed 2017-12-01 | |||||
| 2015-09-30 | $44.67K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $140.78K derived: sum of 2 quarters · filed 2017-12-01 | $121.96K derived: sum of 3 quarters · filed 2017-12-01 | $113.92K 10-K · filed 2017-12-01 | |||||
| 2015-06-30 | $96.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $77.29K derived: sum of 2 quarters · filed 2016-08-09 | $69.24K 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | -$18.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | -$26.87K 10-Q · filed 2016-05-09 | |||||||
| 2014-12-31 | -$8.04K 10-Q · filed 2016-02-08 | ||||||||
| 2014-09-30 | -$12.35K 10-K · filed 2016-12-14 | ||||||||
| 2014-08-31 | -$121.08K 10-K · filed 2016-12-14 | ||||||||
| 2014-06-30 | -$75.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | -$163.33K 10-Q · filed 2015-08-10 | |||||||
| 2014-03-31 | -$87.64K 10-Q · filed 2015-05-11 | ||||||||
| 2013-08-31 | $192.07K 10-K · filed 2015-12-14 | ||||||||
| 2012-08-31 | -$29.74K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |